Ignite Creation Date:
2024-05-06 @ 4:11 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04896697
Status:
RECRUITING
Last Update Posted:
2023-08-25
First Post:
2021-05-06
Brief Title:
Vilastobart XTX101 Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors
Sponsor:
Organization:
Xilio Development Inc